Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
作者信息
Braun F, Lorf T, Grupp C, Schütz E, Sattler B, Canelo R, Müller G A, Ringe B
机构信息
Klinik für Transplantationschirurgie, Georg-August-Universität, Göttingen, Germany.
出版信息
Transplant Proc. 1998 Jun;30(4):1221-3. doi: 10.1016/s0041-1345(98)00218-8.
PMID:9636496
Abstract
摘要
相似文献
1
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
Transplant Proc. 1998 Jun;30(4):1221-3. doi: 10.1016/s0041-1345(98)00218-8.
2
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
Transplant Proc. 1999 Nov;31(7A):69S-71S. doi: 10.1016/s0041-1345(99)00799-x.
3
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
Transplant Proc. 2000 Nov;32(7):2535. doi: 10.1016/s0041-1345(00)01779-6.
4
Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.
Transplant Proc. 2002 Aug;34(5):1689-90. doi: 10.1016/s0041-1345(02)02983-4.
5
Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Transplant Proc. 2000 Nov;32(7):1721-2. doi: 10.1016/s0041-1345(00)01400-7.
6
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Transplant Proc. 1999 Feb-Mar;31(1-2):276-7. doi: 10.1016/s0041-1345(98)01625-x.
7
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.
Transplant Proc. 2002 Aug;34(5):1617-8. doi: 10.1016/s0041-1345(02)03045-2.
8
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk".
Transplant Proc. 2000 Nov;32(7):1688. doi: 10.1016/s0041-1345(00)01414-7.
9
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.
Transplant Proc. 2002 Aug;34(5):1685-6. doi: 10.1016/s0041-1345(02)02982-2.
10
Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results.
Transplant Proc. 2002 Aug;34(5):1591-3. doi: 10.1016/s0041-1345(02)03035-x.
引用本文的文献
1
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.
Zotero 插件